Launch of New Bioinformatics Solutions and R&D of Novel Bioinformatics Pipeline to Augment Growth of Bioinformatics Market
Bioinformatics covers a wide range of scientific areas involving genomics, microbial, and animal and plant sciences. It can be used to design and evaluate sequencing experiments, as well as developing bioinformatics software. Bioinformatics has opened up many new opportunities for researchers due to its focus on information science, specifically computer science. This area of science strives to bridge the gap between the biology and technologies, thus facilitating the meaningful exchange of information.
Market Dynamics
Launch
of new bioinformatics solutions is expected to propel growth of the global
bioinformatics market. For instance, in January 2021, Illumina launched
Illumina Connected Analytics, an integrated bioinformatics solution that
provides a comprehensive, private, cloud-based data platform. Moreover,
integration of deep learning and bioinformatics is also expected enable in-depth
study of glycan molecules for understanding infections, thereby aiding in
growth of the market.
R&D
of novel bioinformatics pipeline to identify viruses in host-associated or
environmental samples is expected to offer lucrative growth opportunities for
players in the global bioinformatics market. High prevalence of cardiovascular
diseases is also expected to aid in growth of the market. For instance, according
to the American Heart Association's Heart and Stroke Statistics 2019 Update,
around 48% of all adults in the U.S. suffered from some type of cardiovascular
disease in 2016.
Emergence
of Covid-19 has led to increasing adoption of bioinformatics, thereby
propelling growth of the global bioinformatics market. For instance, globally,
as of 4:58pm CET, 8 February 2021, there have been 105,805,951 confirmed cases
of COVID-19, including 2,312,278 deaths, as reported to the World Health
Organization. Moreover, increasing funding in bioinformatics is also expected
to aid in growth of the market, For instance, in August 2020, Addex
Therapeutics, a clinical-stage pharmaceutical company, and the SIB Swiss
Institute of Bioinformatics, were awarded a US$ 669 thousand Innosuisse grant
to apply computational approaches developed by SIB to identify new therapeutic
indications for ADX10061, a potent and selective dopamine D1 receptor
antagonist.
Competitive Analysis
Major
players operating in the global bioinformatics market include, Active Motif,
Inc., Illumina, Inc., Life Technologies, Affymetrix, Inc., Agilent
Technologies, Bio-Rad Laboratories, Inc., Qiagen, Knome, Inc., GE Healthcare,
Geneva Bioinformatics SA, Quest Diagnostics, bitBiome, Inc., Intomics, Advanced
BioInformatics GmbH, and Fios Genomics Ltd.
Major
players in the global bioinformatics market are focused on R&D to expand their product
portfolio. For instance, in June 2020, Intomics announced that the company is a
part of the newly funded translate project on personalized diabetes treatment.
Comments
Post a Comment